1. Adjunctive Brexpiprazole: A Review in Major Depressive Disorder

   • Kate McKeage

   Adis Drug Evaluation 05 February 2016 Pages: 91 - 99

   

2. Novel Thrombolytics for Acute Ischemic Stroke: Challenges and Opportunities

   • Nicola Logallo
   • Christopher E. Kvistad
   • Lars Thomassen

   Current Opinion 21 January 2016 Pages: 101 - 108

3. Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date

   • Mary R. Lee
   • Matthew C. H. Rohn
   • Lorenzo Leggio

   Leading Article 01 March 2016 Pages: 109 - 123

4. Potential Role of Oestrogen Modulation in the Treatment of Neurocognitive Deficits in Schizophrenia

   • Thomas W. Weickert
   • Katherine M. Allen
   • Cynthia S. Weickert

   Leading Article Open access 05 February 2016 Pages: 125 - 133

5. The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis

   • Samuel F. Hunter
   • James D. Bowen
   • Anthony T. Reder

   Review Article Open access 29 December 2015 Pages: 135 - 147

   

6. Worldwide Differences in Regulations of Clozapine Use

   • Jimmi Nielsen
   • Corina Young
   • David Taylor

   Review Article 16 February 2016 Pages: 149 - 161

   

7. The Cost Effectiveness of Nalmefene for Reduction of Alcohol Consumption in Alcohol-Dependent Patients with High or Very High Drinking-Risk Levels from a UK Societal Perspective

   • Thor-Henrik Brodtkorb
   • Melissa Bell
   • Philippe Laramée

   Original Research Article 15 February 2016 Pages: 163 - 177